Tütün kontrolü

KARLIKAYA, Celal; Öztuna, Funda; Ozkan, Metin; ÖRSEL, Osman; SOLAK, Aytemur Zeynep

Tütün kontrolü

Celal KARLIKAYA, (Trakya Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Edirne, Türkiye)

Funda ÖZTUNA, (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Trabzon, Türkiye)

Aytemur Zeynep SOLAK, (Ege Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, İzmir, Türkiye)

Metin ÖZKAN, (GATA Göğüs Hastalıkları Anabilim Dalı, Ankara, Türkiye)

Osman ÖRSEL (Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Merkezi, Ankara, Türkiye)

Toraks Dergisi

37 13

Yıl: 2006 Cilt: 7 Sayı: 1 Sayfa Aralığı: 51 - 64 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Tütün kontrolü

Öz:

Tütün, artık hem gelişmiş hem de gelişmekte olan ülkelerdeki önlenebilir ölümlerin başlıca nedenidir. Tütün kullanımı ve buna karşı girişimler değişmezse, 2000'den 2030 kadar tütün kullananların sayısı 1.2 milyardan 1.6 milyara ve yıllık ölümler 4.9 milyondan 10 Milyona ulaşacaktır. Bu artışlar özellikle düşük ve orta gelirli ülkelerde yaşanacaktır. Sigara başlıca kanserler, kalp ve akciğer hastalıklarından olmak üzere ölümlere ve 50'den fazla sağlık problemine yol açar. Gebelikte anne karnında maruziyet düşük doğum ağırlığı, perinatal mortalite, konjenital defektler, çocukluk astımı ve diğer solunumsal sorunlara yol açar. Çevresel sigara dumanına pasif maruziyet akciğer kanseri ve kalp hastalıkları riskini arttırır. Tütünün kontrolü birçok sektörün birlikte hareketini gerektiren karmaşık bir sorundur. Çocukların sigara kullanmasının önlenmesi, içenlerin bırakmasının motivasyonu, bırakma tedavilerinin kolay ulaşılabilir hale getirilmesi, halka açık yerlerde ve iş yerlerinde sigara yasakları ve kapsamlı bir reklam ve promosyon yasağı başlıca tütün kontrol politikalarıdır. Sigara bırakma tedavisi, tütüne bağlı hastalıkların morbidite ve mortalitesini azaltmada tütün kontrol programlarının önemli öğelerinden birisidir. Bu makalede tütün kullanımının insana ve topluma zararları ve tütün kontrol önlemleri gözden geçirilmektedir.

Anahtar Kelime: Epidemiyoloji Tütün kullanım bozukluğu Tütün

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1) Kaufman N, Yach D. Tobacco control-challenges and prospects. Bull World Health Organ 2000;78:867.
2) World Bank. Curbing the Epidemic: Governments and the Economics of Tobacco Control. 1999. Washington, World Bank.
3) Warren CW, Riley L, Asma S et al. Tobacco use by youth: a surveillance report from the Global Youth Tobacco Survey project. Bull World Health Organ 2000;78:868-76.
4) Kocabas A. Orta dereceli okul öğrencilerinde sigara içme alışkanlığı. Ankara Tıp Mecmuası 1988;41:9-22.
5) Kıyak M, Dağoğlu T. Lise öğrencileri arasında sigara kullanımı. İstanbul Halk Sağlığı Bülteni 1990;11:14-7.
6) Dabakoglu T, Kukner S, Vicdan K et al. Smoking, drinking and drug use in female adolescent. Tr J Med Sci 1993; 19: 157-64.
7) Karlıkaya C. Edirne'de orta öğretim öğrencilerinde sigara içme prevalansı. Toraks Dergisi 2002;3:6-12.
8) PIAR Araştırma Ltd. Şti. Sağlık ve Sosyal Yardım Bakanlığı, sigara alışkanlıkları ve sigara ile mücadele kampanyası kamuoyu araştırması raporu. 1988. İstanbul.
9) Vineis P, Airoldi L, Veglia P et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ 2005;330:277.
10) Satman I, Yilmaz T, Sengul A et al. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551-6.
11) Türk Kardiyoloji Derneği. Türkiye Kalp Raporu 2000. İstanbul: Yenilik Basımevi; 2000.
12) Şahin M, Arslandağ M. Kardiyovasküler sistem ve sigara. In: Tür A; ed. Sigaranın bilimsel yüzü. İstanbul: Logos Yayıncılık; 2005.
13) World Health Organization. The tobacco epidemic rages on in Eastern and Central Europe. Fact Sheet No. 156. Geneva, Switzerland; 1997.
14) Dabak Ş. Sigara ve sağlık. In: Tür A; ed. Sigaranın bilimsel yüzü. İstanbul: Logos Yayıncılık, 2004;1-32.
15) US Department of Health and Human Services. Preventing tobacco use among young people: a report of the Surgeon General. US Department of Health and Human Services, CDC, and National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health. Atlanta, Georgia., CDC. 1994.
16) US Department of Health and Human Services. Healthy people 2010 (conference ed, 2 vols). Washington, DC, US Department of Health and Human Services. 2000.
17) Hasan SU. ATS statement-cigarette smoking and health. Am J Respir Crit Care Med 1996;154:1579-80.
18) Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-52.
19) World Health Organization. and Regional Office for Europe. European Strategy for Tobacco Control. Copenhagen, World Health Organization. 2002.
20) US Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. Atlanta, Georgia., US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS Publication No. (CDC) 89-8411. 1989.
21) Behr J, Nowak D. Tobacco smoke and respiratory disease. In: D'Amato G, Holgate ST; eds. The Impact of Air Pollution on Respiratory Health. First Ed. Sheffield: ERS Journals Ltd. Eur Respir Mon, 2002;21:161-79.
22) Peto R. Smoking and death: the past 40 years and the next 40. BMJ 1994;309:937-9.
23) Murray JL, Lopez AD. The global burden of disease, summary. World Bank Publication, 1996.
24) Ash UK. Smoking Statistics: Illness and Death. Fact Sheet No:2. http:// www.ash.org.uk/html/factsheets/html/fact02 html#_edn7; 2003.
25) US Department of Health and Human Services. A Report of the Surgeon General: The health consequences of smoking. Washington (DC), US Department of Health and Human Services. 1982.
26) Foster WM, Langenback EG, Bergofsky EH. Disassociation in the mucociliary function of central and peripheral airways of asymptomatic smokers. Am Rev Respir Dis 1985;132:633-9.
27) Murin S, Bilello KS, Matthay R. Other smoking-affected pulmonary diseases. Clin Chest Med 2000;21:121-37.
28) Beck GJ, Doyle CA, Schachter EN. Smoking and lung function. Am Rev Respir Dis 1981;123:149-55.
29) Cohen V, Khuri FR. Progress in lung cancer chemoprevention. Cancer Control 2003;10:315-24.
30) Fidaner C, Eser SY, Parkin DM. Incidence in Izmir in 1993-1994: first results from Izmir Cancer Registry. Eur J Cancer 2001;37:83-92.
31) Goksel T, Akkoclu A. Turkish Thoracic Society, Lung andPleural Malignancies Study Group. Pattern of lung cancer in Turkey, 1994- 1998. Respiration 2002;69:207-10.
32) Köktürk N, Öztürk C, Kırışoğlu CE. Sigara ve akciğer kanseri. Solunum 2004;5:139-45.
33) Holbrook JH. Nicotine addiction. In: Fauci AS, Martin JB, Braunwald E et al; eds. Harrison's Principles of Internal Medicine. 14th International ed. Vol 2. Health Professional Division, Mcgraw- Hill; 1998;2516-9.
34) American Lung Association.®Fact Sheet. Women and Smoking. http://www.lungusa.org/tobacco/women_factsheet99 html; 2001.
35) Ediger D. Sigara ve astım. In: Sigara ve sağlık. Bursa: 2002;162-70.
36) US Surgeon General. Women and Smoking, A Report of the Surgeon General 2001. CDC's Office on smoking and health. 2001.
37) Mackay J, Amos A. Women and tobacco. Respirology 2003;8:123-30.
38) Karlıkaya C. Sigara ve meslek. Solunum 2004;6:262-75.
39) Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999;36:425-38.
40) Heliovaara M, Aho K, Aromaa A et al. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993;20:1830-5.
41) Christen WG, Glynn RJ, Ajani UA et al. Smoking cessation and risk of age-related cataract in men. JAMA 2000;284:713-6.
42) Tomany SC, Wang JJ, Van Leeuwen R et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004;111:1280-7.
43) Kadunce DP, Burr R, Gress R et al. Cigarette smoking: risk factor for premature facial wrinkling. Ann Intern Med 1991;114:840-4.
44) Physicians for a Smoke-Free Canada (PSC). Health effects of second hand smoke. http://www.smoke-free.ca/factsheets/pdf/ Q&A-healtheffects.pdf; 2006.
45) U.S.Environmental Protection Agency (U.S.EPA). Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. EPA/600/6-90/006F. Washington, DC, EPA Office of Research and Development. 1992.
46) U.S.Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U.S., Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2004.
47) Fagerstrom K. Sigara içmenin epidemiyolojisi. Sigarayı bırakmanın sağlık açısından sonuçları ve yararları. Drugs 2002;62:1-9.
48) Boyacı H, Duman C, Başyiğit İ ve ark. İlkokul çocuklarında çevresel sigara dumanına maruziyetin idrar kotinin düzeyi ile değerlendirilmesi. Tüberk Toraks 2004;52:231-6.
49) Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Morb Mortal Wkly Rep 2002;51:300-3.
50) Crews KM, Payne TJ. Tobacco update: scientific advances, clinical perspectives. Am J Med Sci 2003;326:165-6.
51) Parrott S, Godfrey C, Raw M et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. Thorax 1998;53 (Suppl 5):S1-38.
52) Warner KE. Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage. Pharmacoeconomics 1997;11:538-49.
53) Joossens L, Raw M. Cigarette smuggling in Europe: who really benefits? Tob Control 1998;7:66-71.
54) UICC. UICC Tobacco Control Fact Sheet 4. Tobacco Taxation and Price Policies. Tobacco and Cancer Programme, International Union Against Cancer. http://www.globalink org; 1993.
55) Slama K. Tobacco ad prevention. A guide for low income countries. Paris: International Union Against Tuberculosis and Lung Disease. 1998.
56) Guidelines for school health programs to prevent tobacco use and addiction. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994; 43: 1-18.
57) US Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Georgia., US Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2000.
58) Henningfield JE, Stapleton JM, Benowitz NL et al. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 1993;33:23-9.
59) American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition (DSM-IV). Washington DC: American Psychiatric Association, 1995.
60) CDC. Health Objectives for the Nation Cigarette Smoking Among Adults, United States, 1993. MMWR Morb Mortal Wkly Rep 1994;43:925-30.
61) Hatziandreu EJ, Pierce JP, Lefkopoulou M et al. Quitting smoking in the United States in 1986. J Natl Cancer Inst 1990;82:1402-6.
62) Fiore MC, Novotny TE, Pierce JP et al. Trends in cigarette smoking in the United States. The changing influence of gender and race. JAMA 1989;261:49-55.
63) Pierce JP, Gilpin EA, Emery SL et al. Has the California tobacco control program reduced smoking? JAMA 1998;280:893-9.
64) Hu TW, Sung HY, Keeler TE. Reducing cigarette consumption in California: tobacco taxes vs an anti-smoking media campaign. Am J Public Health 1995;85:1218-22.
65) Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 1997;96:1089-96.
66) Tsevat J. Impact and cost-effectiveness of smoking interventions. Am J Med 1992;93:43S-7S.
67) Cromwell J, Bartosch WJ, Fiore MC et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 1997;278:1759-66.
68) Cummings SR, Rubin SM, Oster G. The cost-effectiveness of counseling smokers to quit. JAMA 1989;261:75-9.
69) West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Thorax 2000;55:987-99.
70) Raw M, Anderson P, Batra A et al. WHO Europe evidence based recommendations on the treatment of tobacco dependence. Tob Control 2002;11:44-6.
71) Bilir N. Birinci basamağın tütün kontrolünde önemi, 2004. [Kişisel İletişim]
72) The state of managed care quality 2. National Committee for Quality Assurance. Washington, D.C., 2000.
73) Fiore MC. US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care 2000;45:1200-62.
74) Tutluoğlu B. Sigara bırakma yöntemleri. Solunum 2003;5:230-6.
75) Yorgancıoğlu A, Esen A. Sigara bağımlılığı ve hekimler. Toraks Dergisi 2000;1:90-5.
76) Marlow SP, Stoller JK. Smoking cessation. Respir Care 2003;48:1238-54.
77) Uzaslan E. Sigarayı bırakma yöntemleri. Sürekli Tıp Eğitim Dergisi 2003;12:166-71.
78) Oğuz Y. Alternatif tıp, tıbbın alternatifi olabilir mi? T Klin Tıbbi Etik 1994;2:8-11.
79) Schwartz, J. L. Review and evaluation of smoking cessation methods: The United States and Canada, 1978–1985. NIH Publication No. 87-2940. 2005. Bethesda (MD), US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Division of Cancer Prevention and Control, 1987.
80) Abbot NC, Stead LF, White AR et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev 2000; CD001008.
81) Schwartz JL. Methods for smoking cessation. Clin Chest Med 1991;12:737-53.
82) Schwartz JL. Evaluation of acupuncture as a treatment for smoking. Am J Acupunct 1988;16:142.
83) White AR, Resch KL, Ernst E. A meta-analysis of acupuncture techniques for smoking cessation. Tob Control 1999;8:393-7.
84) White AR, Rampes H, Ernst E. Acupuncture for smoking cessation. Cochrane Database Syst Rev 2002; CD000009.
85) White AR, Rampes H, Ernst E. Acupuncture for smoking cessation. Cochrane Database Syst Rev 2005; CD000009.
86) Strategies for reducing exposure to environmental tobacco smoke, increasing tobacco-use cessation, and reducing initiation in communities and health-care systems. A report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2000;49:1-11.
87) Tobacco use prevention and control. http://www thecommunityguide org/tobacco; 2005.

APA	KARLIKAYA C, Öztuna F, SOLAK A, Ozkan M, ÖRSEL O (2006). Tütün kontrolü. , 51 - 64.
Chicago	KARLIKAYA Celal,Öztuna Funda,SOLAK Aytemur Zeynep,Ozkan Metin,ÖRSEL Osman Tütün kontrolü. (2006): 51 - 64.
MLA	KARLIKAYA Celal,Öztuna Funda,SOLAK Aytemur Zeynep,Ozkan Metin,ÖRSEL Osman Tütün kontrolü. , 2006, ss.51 - 64.
AMA	KARLIKAYA C,Öztuna F,SOLAK A,Ozkan M,ÖRSEL O Tütün kontrolü. . 2006; 51 - 64.
Vancouver	KARLIKAYA C,Öztuna F,SOLAK A,Ozkan M,ÖRSEL O Tütün kontrolü. . 2006; 51 - 64.
IEEE	KARLIKAYA C,Öztuna F,SOLAK A,Ozkan M,ÖRSEL O "Tütün kontrolü." , ss.51 - 64, 2006.
ISNAD	KARLIKAYA, Celal vd. "Tütün kontrolü". (2006), 51-64.

APA	KARLIKAYA C, Öztuna F, SOLAK A, Ozkan M, ÖRSEL O (2006). Tütün kontrolü. Toraks Dergisi, 7(1), 51 - 64.
Chicago	KARLIKAYA Celal,Öztuna Funda,SOLAK Aytemur Zeynep,Ozkan Metin,ÖRSEL Osman Tütün kontrolü. Toraks Dergisi 7, no.1 (2006): 51 - 64.
MLA	KARLIKAYA Celal,Öztuna Funda,SOLAK Aytemur Zeynep,Ozkan Metin,ÖRSEL Osman Tütün kontrolü. Toraks Dergisi, vol.7, no.1, 2006, ss.51 - 64.
AMA	KARLIKAYA C,Öztuna F,SOLAK A,Ozkan M,ÖRSEL O Tütün kontrolü. Toraks Dergisi. 2006; 7(1): 51 - 64.
Vancouver	KARLIKAYA C,Öztuna F,SOLAK A,Ozkan M,ÖRSEL O Tütün kontrolü. Toraks Dergisi. 2006; 7(1): 51 - 64.
IEEE	KARLIKAYA C,Öztuna F,SOLAK A,Ozkan M,ÖRSEL O "Tütün kontrolü." Toraks Dergisi, 7, ss.51 - 64, 2006.
ISNAD	KARLIKAYA, Celal vd. "Tütün kontrolü". Toraks Dergisi 7/1 (2006), 51-64.